Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Cigna
CI
$73.7B
| $225K | ﹤0.01% |
+1,098
| New | +$201K |
|
|
ADMS
702
DELISTED
Adamas Pharmaceuticals
ADMS
| $223K | ﹤0.01% |
58,963
-79,761
| -57% | -$382K |
|
703
CGI
GIB
$15.1B
| $220K | ﹤0.01% |
2,623
| – | – |
|
704
Vanguard Dividend Appreciation ETF
VIG
$111B
| $220K | ﹤0.01% |
+1,762
| New | +$213K |
|
705
Enbridge
ENB
$119B
| $219K | ﹤0.01% |
+5,495
| New | +$205K |
|
706
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $213K | ﹤0.01% |
3,661
+49
| +1% | +$2.85K |
|
707
Air Products & Chemicals
APD
$65.7B
| $212K | ﹤0.01% |
904
-91
| -9% | -$20.5K |
|
708
American Electric Power
AEP
$69.6B
| $211K | ﹤0.01% |
+2,231
| New | +$206K |
|
709
Cognizant
CTSH
$24.9B
| $211K | ﹤0.01% |
3,400
-189
| -5% | -$11.7K |
|
710
Invesco S&P 500 Equal Weight ETF
RSP
$97B
| $211K | ﹤0.01% |
+1,821
| New | +$202K |
|
711
Campbell Soup
CPB
$6.55B
| $208K | ﹤0.01% |
+4,200
| New | +$199K |
|
712
Carnival Corporation Ltd
CCL
$38.1B
| $207K | ﹤0.01% |
+4,076
| New | +$182K |
|
713
Hershey
HSY
$35.2B
| $206K | ﹤0.01% |
+1,400
| New | +$208K |
|
|
IMGN
714
DELISTED
Immunogen Inc
IMGN
| $206K | ﹤0.01% |
40,436
-122,795
| -75% | -$417K |
|
|
RTL
715
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $206K | ﹤0.01% |
15,521
| – | – |
|
|
BNY
716
Bank of New York Mellon
BNY
$106B
| $200K | ﹤0.01% |
+3,983
| New | +$190K |
|
717
Fluor
FLR
$7.01B
| $189K | ﹤0.01% |
10,022
-38
| -0.4% | -$691 |
|
718
Lumen
LUMN
$6.57B
| $180K | ﹤0.01% |
13,602
+1,658
| +14% | +$22.2K |
|
719
Hewlett Packard
HPE
$63.4B
| $172K | ﹤0.01% |
+10,814
| New | +$173K |
|
720
First Trust Energy AlphaDEX Fund
FXN
$388M
| $166K | ﹤0.01% |
+15,695
| New | +$151K |
|
721
Resideo Technologies
REZI
$5.19B
| $156K | ﹤0.01% |
13,107
-4,335
| -25% | -$49.3K |
|
722
Lloyds Banking Group
LYG
$89.5B
| $142K | ﹤0.01% |
42,843
-21,141
| -33% | -$63.9K |
|
|
SWZ
723
Swiss Helvetia Fund
SWZ
$76.5M
| $140K | ﹤0.01% |
+16,688
| New | +$136K |
|
724
Annaly Capital Management
NLY
$17.1B
| $135K | ﹤0.01% |
+3,576
| New | +$130K |
|
725
SiriusXM
SIRI
$9.98B
| $80K | ﹤0.01% |
1,112
+12
| +1% | +$809 |
|
Similar funds
Ken Fisher's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
- Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.